Sakaguchi Masakiyo, Kinoshita Rie, Tomonobu Nahoko, Sakaguchi Yoshihiko, Futami Junichiro, Yamauchi Akira, Murata Hitoshi, Yamamoto Ken-Ichi, Takahashi Tetta, Gohara Yuma, Ochi Toshiki, Jiang Fan, Komalasari Ni Luh Gede Yoni, Chen Youyi, Ruma I Made Winarsa, Sumardika I Wayan, Zhou Jin, Honjo Tomoko, Kuribayashi Futoshi, Sagayama Kazumi, Toyooka Shinichi, Kondo Eisaku, Inoue Yusuke
Department of Cell Biology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, 2-5-1 Shikata-Cho, Kita-Ku, Okayama-Shi, Okayama, 700-8558, Japan.
Department of Microbiology, Tokushima Bunri University, Sagamihara, Tokushima, Japan.
In Vitro Cell Dev Biol Anim. 2024 Dec;60(10):1215-1227. doi: 10.1007/s11626-024-00992-2. Epub 2024 Nov 21.
The first-generation pCMViR-TSC, implemented through the promoter sandwich rule, yields 10- to 100-fold higher gene expression than the standard plasmid used with the CMV (cytomegalovirus) or CAG promoter. However, the vector's shortcomings limit its utility to transient expression only, as it is not suitable for establishing stable transformants in mammalian cells. To overcome this weakness, we here introduce the improved plasmid vector pSAKA-4B, derived from pCMViR-TSC as a second-generation chromosome-insertable vector. This vector facilitates the linear entry of the expression unit into the TTAA site of DNA universally with transposase assistance. The vector is helpful for the indefinite expression of our target gene. The new vector system is proven here to be efficient in establishing stable transformants with a high likelihood of positive clones that exhibit significantly elevated expression levels of the delivered foreign gene. This system, alongside the first-generation vector, is therefore instrumental for diverse basic research endeavors concerning genes, proteins, cells, and animals, and potentially for clinical applications such as gene therapy.
第一代pCMViR - TSC通过启动子夹心规则构建,其基因表达水平比使用巨细胞病毒(CMV)或CAG启动子的标准质粒高10至100倍。然而,该载体的缺点限制了其仅用于瞬时表达,因为它不适合在哺乳动物细胞中建立稳定的转化体。为克服这一弱点,我们在此引入改进的质粒载体pSAKA - 4B,它源自pCMViR - TSC,是一种第二代可插入染色体的载体。该载体在转座酶的辅助下,能促进表达单元线性插入DNA的TTAA位点。该载体有助于我们目标基因的无限表达。在此证明,新载体系统在建立稳定转化体方面效率很高,产生阳性克隆的可能性很大,这些阳性克隆表现出所导入外源基因的表达水平显著提高。因此,该系统与第一代载体一起,对涉及基因、蛋白质、细胞和动物的各种基础研究工作具有重要意义,并且可能在基因治疗等临床应用中发挥作用。